Itopride Pellets Manufacturer & Supplier
Prokinetic pellets supporting gastrointestinal motility formulations with consistent particle size and reliable downstream handling.
Product overview
Itopride is a gastrointestinal prokinetic used in formulations addressing disorders associated with impaired gastrointestinal motility. The pelletized format provides a flexible platform for pharmaceutical manufacturers and formulation developers requiring controlled particle characteristics and reproducible downstream processing.
Key characteristics
- Pelletized Itopride formulation.
- Consistent particle characteristics for capsule filling.
- Suitable for multiparticulate pharmaceutical development.
- Supports formulation scale-up and commercial manufacturing.
- Available according to the product specifications maintained in the Rraynex product portfolio.
Product specifications
- Product
- Itopride Pellets
- Form
- Pellets
- Therapeutic category
- Prokinetic
- Available strengths
- 25 mg, 50 mg, 60%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Itopride Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Itopride products from Rraynex
- Esomeprazole EC + Itopride SR — Pellets
- Pantoprazole + Itopride — Pellets
- Rabeprazole + Itopride — Pellets